COMPUT BIOL MED 润色咨询

COMPUTERS IN BIOLOGY AND MEDICINE

出版年份:1970 年文章数:2781 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:11.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-12-22 ms2000001131997957 来自上海

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064
    https://doi.org/10.1016/j.compbiomed.2022.106501
    https://doi.org/10.1016/j.compbiomed.2022.105810
    https://doi.org/10.1016/j.compbiomed.2022.105752
    https://doi.org/10.1016/j.compbiomed.2022.105563
    https://doi.org/10.1016/j.compbiomed.2022.105529
    https://doi.org/10.1016/j.compbiomed.2022.105510
    https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X
    https://doi.org/10.1016/j.compbiomed.2022.105444
    https://doi.org/10.1016/j.compbiomed.2022.105397
    https://doi.org/10.1016/j.compbiomed.2022.105366
    https://doi.org/10.1016/j.compbiomed.2022.105356
    https://doi.org/10.1016/j.compbiomed.2022.105382
    https://doi.org/10.1016/j.compbiomed.2022.105347

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-12-16 匿名用户

    期刊不允许共通讯

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-11-06 ms2000001076054986 来自贵州省

    这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-10-25 侠胆医心 来自威斯康星

    COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。

    被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-01-24 ms3000002100323158 来自山东省

    偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic
    经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-04-30 洛洛仔111 来自北京

    On hold 了,哈哈哈

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-04-30 ms7000001772997825 来自江苏省

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:生信
    经验分享:这个杂志被on hold了大家小心了

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-04-30 ms9000001243942992 来自浙江省

    on hold,哈哈哈

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-04-30 148893c2m57(暂无昵称) 来自江苏省

    on hold,没想到

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2244272, encodeId=7e3222442e2e6, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:https://doi.org/10.1016/j.compbiomed.2024.108064<br>https://doi.org/10.1016/j.compbiomed.2022.106501<br>https://doi.org/10.1016/j.compbiomed.2022.105810<br>https://doi.org/10.1016/j.compbiomed.2022.105752<br>https://doi.org/10.1016/j.compbiomed.2022.105563<br>https://doi.org/10.1016/j.compbiomed.2022.105529<br>https://doi.org/10.1016/j.compbiomed.2022.105510<br>https://www.sciencedirect.com/science/article/abs/pii/S001048252200227X<br>https://doi.org/10.1016/j.compbiomed.2022.105444<br>https://doi.org/10.1016/j.compbiomed.2022.105397<br>https://doi.org/10.1016/j.compbiomed.2022.105366<br>https://doi.org/10.1016/j.compbiomed.2022.105356<br>https://doi.org/10.1016/j.compbiomed.2022.105382<br>https://doi.org/10.1016/j.compbiomed.2022.105347, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=df7a6412848, createdName=ms2000001131997957, createdTime=Sun Dec 22 11:02:46 CST 2024, time=2024-12-22, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2242912, encodeId=3979224291203, content=期刊不允许共通讯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Mon Dec 16 14:50:45 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2235498, encodeId=f2d02235498a8, content=这杂志的真实水平不如MDPI旗下任何一个收生信杂志,难怪能被on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Wed Nov 06 14:26:26 CST 2024, time=2024-11-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2233043, encodeId=b0f0223304388, content=COMPUTERS IN BIOLOGY AND MEDICINE被科睿唯安(Clarivate Analytics)列入“On Hold”名单。这一决定引发了广泛关注和讨论。被列入“On Hold”名单的期刊在重新评估期间将暂停收录新发表的文章,这意味着这些期刊的质量和学术诚信正在接受严格审查。<br><br>被列入“On Hold”名单的期刊将接受全面的质量评估,如果不符合标准,可能会被从核心数据库中删除。这一过程不仅影响了期刊本身,也对广大科研工作者的投稿选择产生了重要影响。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Fri Oct 25 06:01:07 CST 2024, time=2024-10-25, status=1, ipAttribution=威斯康星), GetPortalCommentsPageByObjectIdResponse(id=2183588, encodeId=72a121835889b, content=偏重的研究方向:Biology;Computational Biomechanics;Orthopaedic<br>经验分享:请问这个杂志审稿多久啊,我从11月3号under review,到现在一直是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0bb9155553, createdName=ms3000002100323158, createdTime=Wed Jan 24 01:26:36 CST 2024, time=2024-01-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2201241, encodeId=cc7a22012417d, content=On hold 了,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e17c5724173, createdName=洛洛仔111, createdTime=Tue Apr 30 13:49:47 CST 2024, time=2024-04-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2201244, encodeId=d3562201244bd, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:生信<br>经验分享:这个杂志被on hold了大家小心了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b64a9169658, createdName=ms7000001772997825, createdTime=Tue Apr 30 14:09:08 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201311, encodeId=324a220131110, content=on hold,哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=8b835698323, createdName=ms9000001243942992, createdTime=Tue Apr 30 23:39:00 CST 2024, time=2024-04-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201255, encodeId=f5232201255fd, content=on hold,没想到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Tue Apr 30 14:25:23 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2201247, encodeId=3881220124e6c, content=杂志前途未卜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsmALpODGnWib5UaDNI6ztgdmKt9ib3ibKROqTEpGzjvlLbbTLHod3OMBdlb0fCVKtGlvodJCkmsL7Q/132, createdBy=d0d95098090, createdName=ms1469747388241577, createdTime=Tue Apr 30 14:11:16 CST 2024, time=2024-04-30, status=1, ipAttribution=)]
    2024-04-30 ms1469747388241577

    杂志前途未卜

    0

共123条页码: 1/13页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分